Learn More
Medchemexpress LLC Voreloxin hydrochloride | 175519-16-1 | 99.6% | 437.90 | 25 MG

Supplier: Medchemexpress LLC 25MGHY16518
Voreloxin Hydrochloride is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA double-strand breaks, G2 arrest, and apoptosis.
- Induces G2 arrest partially through topoisomerase II in A549 lung cancer cell line.
- Cytotoxic activity requires DNA intercalation.
- Exhibits potent cytotoxic activity in AML cell lines, including MV4-11 and HL-60.
- Shows additive or synergistic activity in acute leukemia cell lines when combined with cytarabine.
- Causes accumulation of cells in the S and G2 phases of the cell cycle.
- Induces bone marrow aplasia in vivo when combined with cytarabine.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.